{
  "drug_name": "GLP-1_agonists",
  "url": "https://wikem.org/wiki/GLP-1_agonists",
  "scraped_at": "2026-01-10T07:53:41.910552",
  "sections": {
    "Background": {
      "text": "Synthetic glucagon-like peptide-1 (GLP-1) receptor agonists\nReleased by L-cells of the small intestine in response to the presence of nutrients\nStimulate insulin release from pancreatic islet cells. It does this by stimulating glucose-dependent insulin release in the islet cells of the pancreas\nSlows gastric emptying times\nIncreases satiety, which decreases drive for food intake",
      "subsections": {
        "GLP-1_Agonist_Types": {
          "text": "Lixisenatide (Lyxumia, Adlyxin)\nSemaglutide (Ozempic, Rybelsus, Wegovy)\nTirzepatide^ (Mounjaro, Zepbound)\n^Dual GLP-1 and GIP agonist",
          "tables": [
            [
              {
                "Short Acting": "Exenatide (Byetta)",
                "Dose": "5-10 mcg SC bid"
              },
              {
                "Short Acting": "Liraglutide (Victoza, Saxenda)",
                "Dose": "0.6-1.8 mg SC daily"
              },
              {
                "Short Acting": "Long Acting",
                "Dose": ""
              },
              {
                "Short Acting": "Exenatide (Bydureon)",
                "Dose": "2 mg SC qwk"
              },
              {
                "Short Acting": "Albiglutide (Tanzeum)",
                "Dose": "30-50 mg SC qwk"
              },
              {
                "Short Acting": "Dulaglutide (Trulicity)",
                "Dose": "0.75-1.5 mg qwk"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": []
    },
    "GLP-1_Agonist_Types": {
      "text": "Lixisenatide (Lyxumia, Adlyxin)\nSemaglutide (Ozempic, Rybelsus, Wegovy)\nTirzepatide^ (Mounjaro, Zepbound)\n^Dual GLP-1 and GIP agonist",
      "subsections": {},
      "tables": [
        [
          {
            "Short Acting": "Exenatide (Byetta)",
            "Dose": "5-10 mcg SC bid"
          },
          {
            "Short Acting": "Liraglutide (Victoza, Saxenda)",
            "Dose": "0.6-1.8 mg SC daily"
          },
          {
            "Short Acting": "Long Acting",
            "Dose": ""
          },
          {
            "Short Acting": "Exenatide (Bydureon)",
            "Dose": "2 mg SC qwk"
          },
          {
            "Short Acting": "Albiglutide (Tanzeum)",
            "Dose": "30-50 mg SC qwk"
          },
          {
            "Short Acting": "Dulaglutide (Trulicity)",
            "Dose": "0.75-1.5 mg qwk"
          }
        ]
      ],
      "links": []
    },
    "Indication": {
      "text": "Diabetes Mellitus\n, Type 2",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Diabetes Mellitus",
          "url": "https://wikem.org/wiki/Diabetes_Mellitus"
        }
      ]
    },
    "Adverse_Reactions": {
      "text": "Nausea\n,\nvomiting\n,\ndiarrhea\nAcute\npancreatitis\nExenatide should not be used in patients with creatinine clearance below 30mL/min\nShould not be used if personal of family history of medullary thyroid cancer or MEN 2A/2B",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Nausea",
          "url": "https://wikem.org/wiki/Nausea"
        },
        {
          "text": "vomiting",
          "url": "https://wikem.org/wiki/Vomiting"
        },
        {
          "text": "diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        },
        {
          "text": "pancreatitis",
          "url": "https://wikem.org/wiki/Pancreatitis"
        }
      ]
    },
    "See_Also": {
      "text": "GLP-1 receptor agonist toxicity\nDiabetes medications\nTirzepatide",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "GLP-1 receptor agonist toxicity",
          "url": "https://wikem.org/wiki/GLP-1_receptor_agonist_toxicity"
        },
        {
          "text": "Diabetes medications",
          "url": "https://wikem.org/wiki/Diabetes_medications"
        },
        {
          "text": "Tirzepatide",
          "url": "https://wikem.org/wiki/Tirzepatide"
        }
      ]
    },
    "References": {
      "text": "Epocrates\nhttp://www.uptodate.com/contents/glucagon-like-peptide-1-receptor-agonists-for-the-treatment-of-type-2-diabetes-mellitus?source=see_link&sectionName=GLUCAGON-LIKE+PEPTIDE-1&anchor=H2#H619400",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}